Pictet Asset Management (UK)’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $40.4M | Sell |
1,152,686
-1,382,087
| -55% | -$48.4M | 0.04% | 384 |
|
|
2021
Q1 | $103M | Buy |
2,534,773
+16,485
| +0.7% | +$672K | 0.12% | 205 |
|
|
2020
Q4 | $109M | Buy |
2,518,288
+1,311,599
| +109% | +$56.8M | 0.14% | 185 |
|
|
2020
Q3 | $66.5M | Buy |
1,206,689
+265,764
| +28% | +$14.7M | 0.1% | 228 |
|
|
2020
Q2 | $59.4M | Buy |
940,925
+348,612
| +59% | +$22M | 0.1% | 230 |
|
|
2020
Q1 | $30.3M | Buy |
592,313
+1,943
| +0.3% | +$99.3K | 0.06% | 292 |
|
|
2019
Q4 | $46.9M | Buy |
590,370
+50,860
| +9% | +$4.04M | 0.08% | 273 |
|
|
2019
Q3 | $26.2M | Buy |
539,510
+100,653
| +23% | +$4.88M | 0.06% | 335 |
|
|
2019
Q2 | $23.1M | Sell |
438,857
-31,528
| -7% | -$1.66M | 0.05% | 354 |
|
|
2019
Q1 | $24.9M | Buy |
470,385
+4,326
| +0.9% | +$229K | 0.05% | 342 |
|
|
2018
Q4 | $19.1K | Sell |
466,059
-8,789
| -2% | -$361 | 0.05% | 377 |
|
|
2018
Q3 | $18M | Buy |
474,848
+57,775
| +14% | +$2.2M | 0.04% | 431 |
|
|
2018
Q2 | $18.9M | Buy |
417,073
+103,353
| +33% | +$4.67M | 0.05% | 406 |
|
|
2018
Q1 | $15.2M | Buy |
+313,720
| New | +$15.2M | 0.04% | 428 |
|